{"id":"https://openalex.org/W4252764405","doi":"https://doi.org/10.2174/978160805205910502010037","title":"Potential New Targets for Antithrombotic Therapy","display_name":"Potential New Targets for Antithrombotic Therapy","publication_year":2010,"publication_date":"2010-12-18","ids":{"openalex":"https://openalex.org/W4252764405","doi":"https://doi.org/10.2174/978160805205910502010037"},"language":"en","primary_location":{"id":"doi:10.2174/978160805205910502010037","doi":"https://doi.org/10.2174/978160805205910502010037","is_oa":false,"landing_page_url":"https://doi.org/10.2174/978160805205910502010037","pdf_url":null,"source":{"id":"https://openalex.org/S4306462908","display_name":"BENTHAM SCIENCE PUBLISHERS eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicinal Chemistry - (Volume 2)","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036237322","display_name":"Andr\u00e1s Gruber","orcid":"https://orcid.org/0000-0001-6212-2247","observed_orcids":["https://orcid.org/0000-0001-6212-2247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andras Gruber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110910994","display_name":"Stephen R. Hanson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen R. Hanson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.73340588,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"37","last_page":"48"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antithrombotic-therapy","display_name":"antithrombotic therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hemostasis","display_name":"hemostasis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/coagulation-pathway","display_name":"coagulation pathway","score":0.6570000052452087},{"id":"https://openalex.org/keywords/platelet-count-reduction","display_name":"platelet count reduction","score":0.75},{"id":"https://openalex.org/keywords/protease-activated-receptor-4","display_name":"PAR4","score":0.8880000114440918},{"id":"https://openalex.org/keywords/protein-c-pathway","display_name":"protein C pathway","score":0.8510000109672546},{"id":"https://openalex.org/keywords/hemostatic-disorders","display_name":"hemostatic disorders","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-target-selection","display_name":"drug target selection","score":0.5370000004768372},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.6919999718666077},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.7960000038146973},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.9549999833106995}],"concepts":[{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.8939239978790283},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3557770848274231},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15286213159561157}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/978160805205910502010037","doi":"https://doi.org/10.2174/978160805205910502010037","is_oa":false,"landing_page_url":"https://doi.org/10.2174/978160805205910502010037","pdf_url":null,"source":{"id":"https://openalex.org/S4306462908","display_name":"BENTHAM SCIENCE PUBLISHERS eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicinal Chemistry - (Volume 2)","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2138604875","https://openalex.org/W4387879095","https://openalex.org/W3010522600","https://openalex.org/W2736925049","https://openalex.org/W4408388728","https://openalex.org/W2788437319","https://openalex.org/W1983129103","https://openalex.org/W2171213274","https://openalex.org/W4213428918","https://openalex.org/W2903471579"],"abstract_inverted_index":{"Thrombosis":[0],"is":[1,56,126],"the":[2,9,17,28,98,115,130,140],"collective":[3],"term":[4],"for":[5,80,93,105,159,179,193],"diseases":[6],"caused":[7],"by":[8],"localized":[10],"accumulation":[11],"of":[12,83,100,114,132,151,200,207,213,221],"circulating":[13,208],"blood":[14],"elements":[15],"within":[16],"vasculature":[18],"that":[19,102,121,145,165,190],"result":[20],"in":[21,41,85,129],"vessel":[22],"occlusion.":[23],"Conventional":[24],"antithrombotic":[25,194,231],"drugs":[26,136],"target":[27,161],"coagulation":[29,202],"pathways":[30,227],"(e.g.,":[31,37,43],"heparins,":[32],"warfarin,":[33],"ximelagatran),":[34],"platelet-dependent":[35],"mechanisms":[36,107],"clopidogrel),":[38],"or":[39,72,218,225],"thrombi":[40],"situ":[42],"streptokinase).":[44],"While":[45],"marketed":[46],"anticoagulants":[47,65],"are":[48,66,103,146,166],"very":[49],"efficacious,":[50],"they":[51],"can":[52,155],"paralyze":[53],"hemostasis,":[54],"which":[55],"a":[57],"potentially":[58,172],"fatal":[59],"condition":[60],"when":[61],"left":[62],"untreated.":[63],"Accordingly,":[64],"only":[67],"rarely":[68],"used":[69],"at":[70,143],"fully":[71],"markedly":[73],"efficacious":[74],"doses,":[75],"e.g.,":[76],"high":[77],"dose":[78],"heparin,":[79],"short":[81],"periods":[82],"time":[84],"closely":[86],"watched":[87],"clinical":[88],"situations.":[89],"Ideally,":[90],"new":[91,135,180,191],"targets":[92],"therapy":[94,195],"would":[95],"lead":[96],"to":[97],"development":[99],"agents":[101],"specific":[104],"thrombusforming":[106],"without":[108],"compromising":[109],"hemostasis.":[110],"However,":[111],"our":[112],"understanding":[113],"molecular,":[116],"cellular,":[117],"and":[118,171,186],"physical":[119],"interactions":[120],"differentiate":[122],"thrombosis":[123,175],"vs.":[124],"hemostasis":[125],"limited.":[127],"Even":[128],"absence":[131],"thrombosis-specific,":[133],"targeting,":[134],"should":[137],"preferentially":[138],"inhibit":[139],"thrombotic":[141],"process":[142],"doses":[144],"relatively":[147],"safe.":[148],"The":[149],"symptomatology":[150],"hemostatic":[152],"pathway":[153,203],"alterations":[154],"serve":[156],"as":[157],"basis":[158],"rational":[160],"selection.":[162],"Hemostatic":[163],"disorders":[164],"compatible":[167],"with":[168],"human":[169],"life":[170],"protective":[173],"against":[174],"provide":[176],"useful":[177],"guidance":[178],"pharmacologic":[181],"strategies.":[182],"Additionally,":[183],"theoretical":[184],"considerations":[185],"experimental":[187],"data":[188],"suggest":[189],"strategies":[192],"might":[196,228],"include:":[197],"1)":[198],"inhibition":[199,212],"intrinsic":[201],"activity,":[204],"2)":[205],"reduction":[206],"platelet":[209,214],"count,":[210],"3)":[211],"protease":[215],"activated":[216],"receptor-4,":[217],"4)":[219],"enhancement":[220],"endogenous":[222],"protein":[223],"C":[224],"thrombolytic":[226],"safely":[229],"improve":[230],"therapy.":[232]},"counts_by_year":[],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2022-05-12T00:00:00"}